Main Page Article Search E-Lerts™ Newsletter: Current E-Lerts™ Newsletter Archives E-Lerts™ Newsletter Recipes Archives Defeat Diabetes® E-Lerts™ Newsletter Subscribe Defeat Diabetes ® News by Daniel H. Rasolt Books You Can Use™ Subscribe to Defeat Diabetes Foundation Mailings
About Diabetes    » A1c    » Adolescents    » Awareness    » Cause    » Children    » Complications    » Control    » Costs    » Cure    » Diagnosis    » Drugs    » Elderly    » Gestational    » Hypoglycemia    » Impaired Fasting Glucose    » Impaired Glucose Tolerance    » Inflammation    » Insulin Resistance    » Insulin Sensitivity    » Men    » Metabolic Syndrome    » Minorities    » Obesity    » Organs    » Other Diseases    » Pancreas    » Pre-Diabetes    » Prevention    » Research    » Risk Factors    » Screening    » Statistics    » Stress    » Syndrome X    » Testing    » Treatments    » Type 1    » Type 2    » Warning Signs    » Women Body Care Children Complications Defeat Diabetes Foundation Drugs Elderly E-Lerts™ Governments & Organizations Health & Fitness Insulin MADDCAP™ Mr. Diabetes® Nutrition Obesity Other Diseases Pregnancy Research Risks Self-Management Supplements Type 1 Warning Signs

 

 

 

     

About Diabetes » Drugs

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

FDA Approves the Next DPP-IV Inhibitor Onglyza Posted: Wednesday, August 05, 2009

Patients with Type 2 diabetes now have a new treatment option: saxagliptin, a dipeptidyl peptidase-4 inhibitor that stimulates the pancreas to create more insulin after meals.

Risk Factors that Lead to Poor Outcomes for Bariatric Surgery Posted: Wednesday, August 05, 2009

Several risk factors may help identify factors linked to poor outcomes for bariatric surgery, according to the results of a study.

Study Finds Common Diabetic Therapy Reduces Risk of Pancreatic Cancer Posted: Wednesday, August 05, 2009

Research suggests promising chemopreventive role for metformin by reducing the risk of pancreatic cancer by 62 percent.

Dementia Meds Increase Risk for Hyperglycemia in Older Diabetics Posted: Wednesday, August 05, 2009

Older diabetics who take antipsychotic medications have an increased risk of ending up in the hospital with elevated blood glucose levels, or hyperglycemia, researchers say.

Income Level Affects Treatment of Hyperglycemia Posted: Wednesday, August 05, 2009

People with diabetes who live in less affluent neighborhoods are more likely to experience delays in treatment for hyperglycemia, according to a study.

Study Finds Intensive Glucose Control Halves Complications of Longstanding Type 1 Diabetes -- Improved Long-Term Outlook Posted: Wednesday, July 29, 2009

Near-normal control of glucose beginning as soon as possible after diagnosis would greatly improve the long-term prognosis of Type 1 diabetes, concludes a study published in the July 27, 2009, issue of the Archives of Internal Medicine, which updates information about the clinical course of Type 1 diabetes.

Researchers Implant Pig Cells in Type 1 Diabetics Posted: Wednesday, July 29, 2009

A New Zealand biotech company began a trial last week that implanted cells from newborn pigs into eight human volunteers as an experimental treatment for their diabetes and the participants will not use immunosuppressant drugs.

A Step Closer to Regenerating Beta Cells Posted: Wednesday, July 22, 2009

US scientists have come a step closer to finding a way to help treat people with diabetes by reactivating their own insulin-producing beta cells in the pancreas. They discovered a hitherto unknown role for a well known protein: it helps immature endocrine systems generate new pancreatic islet cells, which include the insulin-producing beta cells.

New Once-daily Treatment for Type 2 Diabetes Posted: Wednesday, July 15, 2009

A new treatment for Type 2 diabetes may soon be a reality in the U.S.. Liraglutide (Victoza), a once-daily injectable treatment for Type 2 diabetes, is pharmaceutical company Novo Nordisk's latest brain child and has been approved by the E.U.

Lantus Insulin: Link to Cancer Shaky - Update Posted: Wednesday, July 08, 2009

There is conflicting data over possible cancer risk from Lantus Insulin, but another alternative exists that can reduce your risk of cancer.

 

 

 

 

 

 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.